Any stock, in context
COHANCE · Healthcare
Cohance Lifesciences Ltd.
Observation · 15 Oct 2026
How these are readCohance Lifesciences closed at ₹460.0 on 15 Oct 2026, 11.3% above its 200-day average and 2.5% above its 50-day average: above both lines. It sits 49.2% below its highest close of the past year, in the second fifth of its one-year range. Over three months it rose 4.1%, against a median of −2.7% for its sector (146 stocks) and −5.1% for every stock observed.
- vs 200-day
- +11.3%
- the long line
- vs 50-day
- +2.5%
- the short line
- From 52w high
- −49.2%
- ₹266.7₹917.9
- 3 months
- +4.1%
- sector median −2.7% · 51 of 146
Nifty Smallcap 250 · Healthcare · EQ series · median traded value ₹26 crore a day. A description of where the price sits, not a view on the stock.
- 1D
- +3.22%
- 1W
- –
- 1M
- +8.58%
- 3M
- +4.09%
- YTD
- –
- 1Y
- −47.08%
Quotes come from Yahoo Finance through this site's server and are cached for fifteen minutes; when the provider fails, the stored close is shown and labelled. The observation is computed from the latest snapshot. For research and education only; not investment advice.